272 related articles for article (PubMed ID: 7984150)
1. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
Birnbaumer M; Gilbert S; Rosenthal W
Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
[TBL] [Abstract][Full Text] [Related]
2. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.
Sadeghi H; Robertson GL; Bichet DG; Innamorati G; Birnbaumer M
Mol Endocrinol; 1997 Nov; 11(12):1806-13. PubMed ID: 9369448
[TBL] [Abstract][Full Text] [Related]
3. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
Sadeghi HM; Innamorati G; Birnbaumer M
Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
[TBL] [Abstract][Full Text] [Related]
6. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
Schoneberg T; Yun J; Wenkert D; Wess J
EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
[TBL] [Abstract][Full Text] [Related]
7. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
Faerch M; Christensen JH; Rittig S; Johansson JO; Gregersen N; de Zegher F; Corydon TJ
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1518-25. PubMed ID: 19812297
[TBL] [Abstract][Full Text] [Related]
8. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.
Inaba S; Hatakeyama H; Taniguchi N; Miyamori I
J Clin Endocrinol Metab; 2001 Jan; 86(1):381-5. PubMed ID: 11232028
[TBL] [Abstract][Full Text] [Related]
9. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
Robben JH; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
[TBL] [Abstract][Full Text] [Related]
10. Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus.
Postina R; Ufer E; Pfeiffer R; Knoers NV; Fahrenholz F
Mol Cell Endocrinol; 2000 Jun; 164(1-2):31-9. PubMed ID: 11026555
[TBL] [Abstract][Full Text] [Related]
11. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.
Yokoyama K; Yamauchi A; Izumi M; Itoh T; Ando A; Imai E; Kamada T; Ueda N
J Am Soc Nephrol; 1996 Mar; 7(3):410-4. PubMed ID: 8704106
[TBL] [Abstract][Full Text] [Related]
12. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site.
Schülein R; Liebenhoff U; Müller H; Birnbaumer M; Rosenthal W
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):611-6. PubMed ID: 8573100
[TBL] [Abstract][Full Text] [Related]
13. Two vasopressin type 2 receptor gene mutations R143P and delta V278 in patients with nephrogenic diabetes insipidus impair ligand binding of the receptor.
Tsukaguchi H; Matsubara H; Mori Y; Yoshimasa Y; Yoshimasa T; Nakao K; Inada M
Biochem Biophys Res Commun; 1995 Jun; 211(3):967-77. PubMed ID: 7598729
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase.
Rosenthal W; Antaramian A; Gilbert S; Birnbaumer M
J Biol Chem; 1993 Jun; 268(18):13030-3. PubMed ID: 8514744
[TBL] [Abstract][Full Text] [Related]
15. The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues.
Schülein R; Zühlke K; Oksche A; Hermosilla R; Furkert J; Rosenthal W
FEBS Lett; 2000 Jan; 466(1):101-6. PubMed ID: 10648821
[TBL] [Abstract][Full Text] [Related]
16. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
Armstrong SP; Seeber RM; Ayoub MA; Feldman BJ; Pfleger KD
PLoS One; 2013; 8(6):e65885. PubMed ID: 23762448
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
[TBL] [Abstract][Full Text] [Related]
18. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M
J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098
[TBL] [Abstract][Full Text] [Related]
19. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
Schöneberg T; Schulz A; Biebermann H; Grüters A; Grimm T; Hübschmann K; Filler G; Gudermann T; Schultz G
Hum Mutat; 1998; 12(3):196-205. PubMed ID: 9711877
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.
Bockenhauer D; Carpentier E; Rochdi D; van't Hoff W; Breton B; Bernier V; Bouvier M; Bichet DG
Nephron Physiol; 2010; 114(1):p1-10. PubMed ID: 19816050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
